Company news

Charles River Laboratories International, Inc. (NYSE:CRL) news

Every Charles River Laboratories International, Inc. press release and news update in one place — announcements, filings coverage, and company updates for in...

Charles River Laboratories International, Inc. (NYSE:CRL) news

Press releases & updates

Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Genera...

Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call

Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

Charles River Laboratories Announces First-Quarter 2026 Results

Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities

Charles River Highlights Effectiveness of VCGs in Toxicology

Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call

Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association

NSG Bio and Charles River Sign Memorandum of Understanding to Strengthen Support for Biotech Innovation in Singapore

Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit

Charles River Laboratories to Present at TD Cowen and Barclays Conferences

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

Charles River Laboratories Provides Update on Planned Divestitures

Charles River Laboratories Announces Executive Appointments

Mariner Pairs with State Street to Scale Operations and Support Growth to 5,000 Advisors via Charles River’s Wealth Platform

Charles River Wealth to Expand Capabilities Supporting Private Assets within Unified Managed Accounts (UMA)

Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call

Charles River Enters Manufacturing Collaboration with Gazi University

Charles River Laboratories Provides Business Updates

Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan

Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

Akadeum Life Sciences Announces Establishment of the Akadeum CDMO Alliance Program

T. Rowe Price Transitions to Charles River’s Enterprise Multi-Asset Investment Management Platform

Charles River Laboratories to Present at Evercore Healthcare Conference

Charles River Laboratories to Present at Jefferies Global Healthcare Conference

Charles River Laboratories Provides Update on Strategic Review

Charles River Laboratories Announces Third-Quarter 2025 Results

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

Jacobi Partners with Charles River to Empower Scalable Model Portfolio Management

Charles River Laboratories Announces Chief Financial Officer Transition

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to ...

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Campbell’s Appoints Kelly L. Palumbo Senior Vice President, Controller and Chief Accounting Officer

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

Charles River Laboratories Announces Second-Quarter 2025 Results

Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership

Charles River Joins Elly’s Team to Drive Rare Disease Gene Therapy Development

Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call

Myrtelle Launches Manufacturing of First-in-Class Gene Therapy for Canavan Disease in Strategic Alliance with Charles River and Viralgen

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

Charles River Laboratories to Present at William Blair and Jefferies Conferences

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research